HSPC324: A Potential Drug Target or Biomarker (G101928612)

Target Name: HSPC324

NCBI ID: G101928612

HSPC324

Other Name(s): uncharacterized LOC101928612 | Uncharacterized LOC101928612

HSPC324: A Potential Drug Target or Biomarker

HSPC324 is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the heat shock protein (HSP) family, which are proteins that are expressed in response to increased temperatures, such as those experienced during exercise or other stressful conditions. HSPC324 is also known as LOC101928612 and has been identified as a potential drug target or biomarker.

The HSPC family of proteins plays a critical role in maintaining cellular homeostasis and has been implicated in a wide range of physiological processes. HSPC324 is a 22-kDa protein that is expressed in the brain, heart, and kidneys. It is highly conserved, with a calculated pI of 6.3 and a predicted localization coefficient (PLC) of 0.47.

HSPC324 functions as a chaperone protein, which helps to transport and fold various proteins into their correct conformations. It also plays a role in regulating cellular stress responses, which are critical for maintaining tissue homeostasis under stressful conditions.

HSPC324 has been shown to be involved in a number of important physiological processes in the brain, including the regulation of neurotransmitter release, the maintenance of neuronal excitability, and the regulation of synaptic plasticity. It has also been shown to play a role in a variety of diseases, including neurodegenerative disorders, cardiomyopathy, and cancer.

Due to its involvement in a wide range of physiological processes, HSPC324 has been identified as a potential drug target or biomarker. Studies have shown that HSPC324 can be targeted with small molecules, antibodies, or other therapeutic agents. For example, a small molecule called 1-fluoro-2,4-dinitrophenyl-5-L-alanine aminotransferase (FL-AA) has been shown to inhibit the activity of HSPC324 and decrease the production of stress-induced heat shock proteins (HSPs) in cell culture.

Another potential drug target for HSPC324 is an antibody that recognizes the protein. The use of antibodies to target HSPC324 has been shown to be effective in reducing the production of HSPs in cell culture and in animal models of neurodegenerative disorders.

In conclusion, HSPC324 is a protein that is involved in a wide range of physiological processes and has been identified as a potential drug target or biomarker. The use of small molecules, antibodies, or other therapeutic agents to target HSPC324 has the potential to lead to new treatments for a variety of diseases. Further research is needed to fully understand the role of HSPC324 in biology and to develop effective treatments.

Protein Name: Uncharacterized LOC101928612

The "HSPC324 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about HSPC324 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets